Abstract:
A key injection service module for an asset management system is provided for a secure means of injecting keys into products. To provide this service, a controller is used to define one or more key types defining the format of the keys in a file. The controller is then used to define a product model, and then to bind each key type to the product models.
Abstract:
An authenticated RFID system is provided that uses elliptic curve cryptography (ECC) to reduce the signature size and read/write times when compared to traditional public key implementations such as RSA. Either ECDSA or ECPVS can be used to reduce the signature size and ECPVS can be used to hide a portion of the RFID tag that contains sensitive product identifying information. As a result, smaller tags can be used or multiple signatures can be written at different stages in a manufacturing or supply chain. A key management system is used to distribute the verification keys and aggregate signature schemes are also provided for adding multiple signatures to the RFID tags, for example in a supply chain.
Abstract:
A system and method for controlling a production process for producing a product is provided in which overproduction may be inhibited by introducing a separation of duties within a production process Typically a producer will contract out the various stages of a production process to multiple contractors. In general, separation of duties involves purposefully separating production stages, for silicon chips or other products, so that the end product has been handled or "touched", by each subcontractor, in order for the end product to be fully functional This is achieved by way of a module having a mathematical transform for intercepting and transforming data flow in the product The mathematical transform requiring a key to be operable, the product requiring successful operation of the mathematical transform to be operable and the key is divided into a plurality of portions of sensitive data which are added during production of the product in a plurality of stages
Abstract:
A key injection service module for an asset management system is provided for a secure means of injecting keys into products. To provide this service, a controller is used to define one or more key types defining the format of the keys in a file. The controller is then used to define a product model, and then to bind each key type to the product models.
Abstract:
A pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal comprising administration of a nicotine receptor partial agonist or a pharmaceutically acceptable salt thereof; and an acetylcholinesterase inhibitor, butylcholinesterase inhibitor, an estrogenic agent, selective estrogen receptor modulator or muscarinic agonist or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier. The nicotine receptor partial agonist and acetylcholinesterase inhibitor, butylcholinesterase inhibitor, estrogen, selective estrogen receptor modulator or muscarinic agonist are present in amounts that render the composition effective enhancing cognition or in the treatment of diseases of cognitive dysfunction including but not limited to Alzheimer's Disease, mild cognitive impairment, age-related cognitive decline, vascular dementia, Parkinson's disease dementia, Huntington's Disease, Stroke, TBI, AIDS associated dementia and schizophrenia. The method of using these compositions is also disclosed.
Abstract:
A pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal comprising administration of a nicotine receptor partial agonist or a pharmaceutically acceptable salt thereof; and an acetylcholinesterase inhibitor, butylcholinesterase inhibitor, an estrogenic agent, selective estrogen receptor modulator or muscarinic agonist or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier. The nicotine receptor partial agonist and acetylcholinesterase inhibitor, butylcholinesterase inhibitor, estrogen, selective estrogen receptor modulator or muscarinic agonist are present in amounts that render the composition effective enhancing cognition or in the treatment of diseases of cognitive dysfunction including but not limited to Alzheimer's Disease, mild cognitive impairment, age-related cognitive decline, vascular dementia, Parkinson's disease dementia, Huntington's Disease, Stroke, TBI, AIDS associated dementia and schizophrenia. The method of using these compositions is also disclosed.
Abstract:
A serialization service module is provided for configuring an asset management system to provide a secure means of generating, assigning to chips (or other electronic objects or devices), and tracking unique serial numbers. To provide this service, a controller is used to define a product model, then to define one or more serialization schemas to be bound to each product model. Each serialization schema contains a range of serial numbers for a particular product. The serial number schemas are sent over a secure, encrypted connection to appliances at the manufacturer's location. Agents can then request serial number values by product name. The serial numbers are generated by the appliance, metered, and provided to the agents. The serial numbers are then injected sequentially into each die in a chip manufacturing process using the agent.
Abstract:
A system and method for remote device registration, to monitor and meter the injection of keying or other confidential information onto a device, is provided. A producer who utilizes one or more separate manufacturers, operates a remote module that communicates over forward and backward channels with a local module at the manufacturer. Encrypted data transmissions are sent by producer to the manufacturer and are decrypted to obtain sensitive data used in the devices. As data transmissions are decrypted, credits from a credit pool are depleted and can be replenished by the producer through credit instructions. As distribution images are decrypted, usage records are created and eventually concatenated, and sent as usage reports back to the producer, to enable the producer to monitor and meter production at the manufacturer. In an alternative arrangement overproduction may be inhibited by introducing a separation of duties within a manufacturing process. Typically a producer will contract out the various stages of manufacturing to multiple contractors. In general, separation of duties involves purposefully separating manufacturing stages, for silicon chips or other devices, so that the end product must have been “touched”, by each subcontractor, in order for the end product to be fully functional.
Abstract:
A partial revocation list and a system and method for using the partial revocation list for tracking the authenticity of replacement cartridges in a manufactured device to inhibit cloning of the cartridges is provided. A revocation pool is maintained by a manufacturer who chooses a partial revocation list from the revocation pool to store in the memory of the cartridge. The device stores its own revocation list, informs the manufacturer of cartridges which have been used and checks when a new device is installed to ensure a cloned replacement is not being used. The partial revocation list distributes enough revocation information to devices to statistically impair the cartridge yield of a cloning operation.
Abstract:
The present invention relates to certain benzoamide piperidine containing compounds of formula I and related compounds that exhibit activity as NK-1 receptor antagonists, ( e.g. , substance P receptor antagonists), to pharmaceutical compositions containing them, and to their use in the treatment and prevention of central nervous system disorders, inflammatory disorders, cardiovascular disorders, ophthalmic disorders, gastrointestinal disorders, disorders caused by helicobacter pylori , disorders of the immune system, urinary incontinence, pain, migraine, emesis, angiogenesis and other disorders. (I)